Trump diagnosed with common vein condition after ankle swelling raises concerns

Trump diagnosed with common vein condition after ankle swelling raises concerns


First Lady Melania Trump, President Donald Trump, FIFA President Gianni Infantino and his wife, Leena Al Ashqar, attend the FIFA Club World Cup 2025 final football match between England’s Chelsea and France’s Paris Saint-Germain at MetLife Stadium in East Rutherford, New Jersey, July 13, 2025.

Charly Triballeau | AFP | Getty Images

President Donald Trump underwent a comprehensive medical exam that revealed he has a common vein disorder but cleared him of more serious illnesses, the White House said Thursday.

The White House disclosed the 79-year-old president’s medical information in response to speculation after photos showed Trump with swollen ankles.

Press secretary Karoline Leavitt said Trump noticed the swelling in recent weeks and received a thorough evaluation by the White House medical unit.

He was diagnosed with chronic venous insufficiency, which Leavitt described as a “benign and common condition, particularly in individuals over the age of 70.”

Chronic venous insufficiency occurs when a person’s leg veins are damaged, restricting circulation and causing blood to pool in the legs, according to the Cleveland Clinic.

Chronic venous insufficiency affects about 1 in 20 adults, and the risk increases with age, according to the clinic.

Leavitt said Trump was not in any pain from the condition.

A bruise is visible on President Donald Trump’s right hand that appeared to be covered with makeup, as Trump waited to greet Crown Prince Salman bin Hamad Al Khalifa of Bahrain as he arrived outside the West Wing of the White House, July 16, 2025.

Mehmet Eser | AFP | Getty Images

Leavitt also addressed bruises periodically visible on the back of Trump’s hand. She said they were caused by irritation from “frequent handshaking,” coupled with his aspirin regimen.

The medical exam found no evidence of deep vein thrombosis or arterial disease, Leavitt said.

Trump’s blood test results were all within “normal limits,” and an echocardiogram confirmed “normal cardiac structure and function” with “no signs of heart failure, renal impairment or systemic illness,” she added.

Leavitt said in Thursday’s briefing that bruising like that seen on Trump’s hands is a common side effect of regularly using aspirin, which Trump takes as part of a “standard cardiovascular prevention regimen.”

“The president remains in excellent health, which I think all of you witness on a daily basis here,” she said.

White House physician Sean Barbabella wrote in an April memo that Trump “remains in excellent physical health” and is “fully fit” to perform the duties of the presidency.

Read Thursday’s full memo from Barbabella below.

President Donald Trump’s health status update.

Courtesy: The White House

This is developing news. Please check back for updates.



Source

Abbott stock fell victim to an old earnings season truth: It’s all about the guidance
Health

Abbott stock fell victim to an old earnings season truth: It’s all about the guidance

Shares of Abbott Laboratories fell Thursday after the diversified health-care company delivered a solid second quarter but left investors disappointed with forward guidance. Revenue in the three months ended June 30 rose 7.4% to $11.14 billion, outpacing the $11.07 billion consensus estimate, according to estimates compiled by LSEG. Organic sales , excluding Covid testing results, […]

Read More
Bristol Myers Squibb, Pfizer to sell blockbuster blood thinner Eliquis at 40% discount
Health

Bristol Myers Squibb, Pfizer to sell blockbuster blood thinner Eliquis at 40% discount

Bristol Myers Squibb and Pfizer on Thursday said they will start selling their blockbuster blood thinner, Eliquis, directly to patients at a more than 40% discount. The move comes as the Trump administration ramps up pressure on the pharmaceutical industry to cut drug prices, and threatens to impose sweeping tariffs on pharmaceuticals imported into the […]

Read More
Swiss pharma giant Novartis bets on a breast cancer blockbuster as sales rise
Health

Swiss pharma giant Novartis bets on a breast cancer blockbuster as sales rise

Boxes of tablets, produced by Novartis AG, sit on a pharmacy counter. Bloomberg | Bloomberg | Getty Images Swiss pharmaceutical firm Novartis said Thursday that it expects its Kisqali breast cancer treatment to be the next blockbuster drug within its portfolio, as it looks to shift reliance away from its Entresto heart failure therapy. Sales of Kisqali, […]

Read More